These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15971088)

  • 1. [Health economics studies in dermatology].
    Rogalski C; Simon J; Paasch U
    Hautarzt; 2006 Apr; 57(4):297-302. PubMed ID: 15971088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Economic evaluation in health care].
    Zechmeister I; Radlberger P
    Wien Med Wochenschr; 2009; 159(5-6):160-8. PubMed ID: 19343294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Processes of psoriasis health care in Germany--long-term analysis of data from the statutory health insurances.
    Augustin M; Glaeske G; Schäfer I; Rustenbach SJ; Hoer A; Radtke MA
    J Dtsch Dermatol Ges; 2012 Sep; 10(9):648-55. PubMed ID: 22525221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The status of health economic evaluation within decision making in Austria.
    Zechmeister-Koss I; Stanak M; Wolf S
    Wien Med Wochenschr; 2019 Sep; 169(11-12):271-283. PubMed ID: 30868427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Decision support through economic evaluation from the perspective of science in Germany].
    Graf von der Schulenburg JM
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2012 May; 55(5):660-7. PubMed ID: 22526854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Health economics, pharmacoeconomics and prescriptions in dermatology].
    Berdeaux G
    Ann Dermatol Venereol; 2000 Mar; 127(3):324-8. PubMed ID: 10804314
    [No Abstract]   [Full Text] [Related]  

  • 8. [Quantitative analysis of drug expenditures variability in dermatology units].
    Moreno-Ramírez D; Ferrándiz L; Ramírez-Soto G; Muñoyerro MD
    Farm Hosp; 2013; 37(5):366-71. PubMed ID: 24128098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the EQ-5D in the economic evaluation of dermatological conditions and therapies.
    Pereira FR; Basra MK; Finlay AY; Salek MS
    Dermatology; 2012; 225(1):45-53. PubMed ID: 22922888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding the cost of dermatologic care: A survey study of dermatology providers, residents, and patients.
    Steen AJ; Mann JA; Carlberg VM; Kimball AB; Musty MJ; Simpson EL
    J Am Acad Dermatol; 2017 Apr; 76(4):609-617. PubMed ID: 28189269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ethics versus economics in public health? On the integration of economic rationality in a discourse of public health ethics].
    Rothgang H; Staber J
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2009 May; 52(5):494-501. PubMed ID: 19330273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health economic methods: cost-minimization, cost-effectiveness, cost-utility, and cost-benefit evaluations.
    Higgins AM; Harris AH
    Crit Care Clin; 2012 Jan; 28(1):11-24, v. PubMed ID: 22123096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [DRGs in dermatology: results of the DRG evaluation project of the German Society of Dermatology (DDG)].
    Fürstenberg T; Rompel R; Gollnick H; Sterry W; Luger TA; Hensen P; Roeder N
    J Dtsch Dermatol Ges; 2004 Jan; 2(1):24-30. PubMed ID: 16281879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Not Available].
    Wolf E; Rüsenberg R
    MMW Fortschr Med; 2015 Jun; 157 Suppl 2():42-5. PubMed ID: 26048120
    [No Abstract]   [Full Text] [Related]  

  • 15. [Analysis of compound prescriptions by practicing dermatologists. A study of 72,615 prescriptions for patients insured by the North Rhine-Westphalia BKK].
    Altmeyer P; Bergmeyer V; Wienand W
    Hautarzt; 1997 Jan; 48(1):12-20. PubMed ID: 9132381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioethics: Under the Skin and on the Surface.
    Chadwick R
    Bioethics; 2015 Sep; 29(7):ii. PubMed ID: 26246461
    [No Abstract]   [Full Text] [Related]  

  • 17. [Health in older age: cost of illness and cost-effectiveness of prevention].
    Brandes I; Walter U
    Z Gerontol Geriatr; 2007 Aug; 40(4):217-25. PubMed ID: 17701113
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is rehabilitation worth it? : Review of economic evaluations of rehabilitation in Germany].
    Krauth C; Bartling T
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2017 Apr; 60(4):394-401. PubMed ID: 28224185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation: what does a nurse manager need to know?
    Douglas HR; Normand C
    J Nurs Manag; 2005 Sep; 13(5):419-27. PubMed ID: 16108780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International standards for health economic evaluation with a focus on the German approach.
    Riedel R; Repschläger U; Griebenow R; Breitkopf S; Schmidt S; Guhl A
    J Clin Pharm Ther; 2013 Aug; 38(4):277-85. PubMed ID: 23621433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.